INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 01, 2020 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5 | $598.58 | 28,838 |
| Aug 28, 2020 |
Director
Trans History: 60
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 177 | $598.91 | 41,256 |
| Aug 11, 2020 |
Director
Trans History: 742
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 718 | $599.37 | 80,899 |
| Jun 01, 2020 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 15 | $599.59 | 28,823 |
| Aug 28, 2020 |
Director
Trans History: 60
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5,730 | $599.67 | 35,526 |
| Aug 05, 2021 |
Director
Trans History: 65
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 2,559 | $600.00 | 891 |
| Oct 05, 2020 |
Director
Trans History: 381
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 9,212 | $600.00 | 5,643 |
| Oct 05, 2020 |
SVP Commercial
Trans History: 139
|
SVP Commercial | Form 4 | Open market or private sale of non-derivative or derivative security | 1,000 | $600.00 | 13,963 |
| Jun 05, 2020 |
Director
Trans History: 65
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 2,559 | $600.00 | 643 |
| Aug 05, 2021 |
Director, President and Chief Scientific
Trans History: 617
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 50,000 | $600.06 | 937,483 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.